Answer
Risedronate sodium hemipentahydrate preserves osteoblast activity and bone mineralisation while reducing bone turnover by inhibiting osteoclast-mediated bone resorption.
Sources for this answer
- Risedronate Sodium 35 mg Film-coated TabletsSandoz Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated
Sources checked